Delivery Order SPE2DX22D0010-SPE2D826FBC35
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,658.73 for Nucynta Tabs 50mg on November 6, 2025, with completion scheduled for November 7, 2025. This competitively awarded, firm fixed-price contract serves the Department of Defense's Medical Supply Chain and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under a larger contract vehicle, reflecting the company's role as a critical...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $12,642.22 for Nucynta Tabs 75mg, a pain management pharmaceutical, by the Defense Logistics Agency's Medical Supply Chain on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and specifies performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Nucynta Tabs 75mg, a pain management pharmaceutical. This competitively awarded, non-set-aside contract carries a ceiling value of $12,375.14 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 30, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on October 22, 2025, for Nucynta ER 250 mg tablets (60-count supply). The contract is valued at $1,460.09 with a firm fixed price structure and an ultimate completion date of October 23, 2025. This award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,895.80 to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Nucynta Tabs 75mg, a pain management pharmaceutical. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by October 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order with a Firm Fixed Price valued at $1,351.56. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, covers the supply of the pain medication Nucynta 75 mg tablets. The contract has a period of performance through November 5, 2024 and was not set aside for any specific business type. Amerisourcebergen holds a $999,999,999...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,230.11 for Nucynta Tabs 100mg on August 21, 2025. This firm fixed-price contract, which has no set-aside designation, was funded by the Defense Logistics Agency's Medical Supply Chain and will be performed at the awardee's Conshohocken facility, with an ultimate completion date of August 22, 2025. The delivery order represents a short-duration...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,789.57 for 100 tablets of Nucynta 75 mg on September 2, 2025, with completion targeted for September 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's medical procurement...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,288.63 on July 25, 2025, for the supply of Nucynta Tabs 50mg under a firm fixed price contract. This non-set-aside award is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by July 28, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 8, 2025, for 60 tablets of Nucynta ER 200 mg. This firm fixed-price, competitively awarded contract carries a ceiling value of $2,411.52 and is scheduled for completion by September 9, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBC35Delivery Order
AmerisourceBergen Drug Corp received a delivery order award for Nucynta Tabs 75mg, a pain management pharmaceutical, valued at $12,160.31 with a firm fixed price structure. The contract was competitively awarded without a set-aside designation and will be completed by November 18, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain, a defense-oriented federal procurement entity, with the place of performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a drawdown from AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's proven capability to fulfill federal medical procurement requirements across multiple therapeutic domains, demonstrated through numerous competitively awarded contracts, positions the company as a critical pharmaceutical distributor for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.2k | 11/17/25 |